PointState Capital Portfolio holdings
PointState Capital manages private investment funds and was started in January 2011; Zachary Schreiber is its chairman, chief executive, chief investment officer and principal owner. The funds mix long/short stock picking, global macro, commodities, high-yield and distressed credit, and event-driven and relative value trades. One group of its funds, PointArgentum, invests mainly in Argentine securities. Its investors are mostly charitable foundations, endowments, funds that invest in other funds, family investment entities, trusts and high net worth individuals.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX
RTX
|
+$191M |
| 2 |
United Airlines
UAL
|
+$156M |
| 3 |
Delta Air Lines
DAL
|
+$150M |
| 4 |
VER
VEREIT
VER
|
+$127M |
| 5 |
Fidelity National Financial
FNF
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$382M |
| 2 |
Marathon Petroleum
MPC
|
+$200M |
| 3 |
Pioneer Natural Resources
PXD
|
+$162M |
| 4 |
Cheniere Energy
LNG
|
+$143M |
| 5 |
Teva Pharmaceutical Industries
TEVA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.73% |
| 2 | Industrials | 20.86% |
| 3 | Energy | 10.89% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Technology | 7.31% |
Similar funds
PointState Capital's Q4 2014 Portfolio in Review
As of Q4 2014, PointState Capital held 149 positions worth $5.87B, up 6.4% from $5.52B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
PointState Capital's Q4 2014 filing shows 49 new, 32 increased, 27 reduced and 36 closed positions. Its largest new stake was RTX: 1,766,600 shares worth $203M. The largest sale was AbbVie, an estimated $382M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Industrials and Energy.
- PointState Capital's largest Q4 2014 buy was RTX: 1,766,600 shares worth $203M.
- PointState Capital added most to United Airlines in Q4 2014, an estimated $156M increase.
- PointState Capital's biggest Q4 2014 reduction was AbbVie, cutting an estimated $382M.
- PointState Capital fully exited Marathon Petroleum in Q4 2014, selling an estimated $200M.
- PointState Capital's ten largest holdings make up 38% of its $5.87B portfolio in Q4 2014.
- PointState Capital opened 49 new positions and closed 36 in Q4 2014.
- PointState Capital's portfolio value rose 6.4% quarter-over-quarter to $5.87B.
Based on PointState Capital's 13F filing for Q4 2014, filed 17 Feb 2015.